BitFrontier Capital Holdings, Inc. (OTCID: BFCH), doing business as UNLOCKD Inc., reported encouraging early operating results for its recently acquired subsidiary Ancient Extracts USA, with preliminary May revenue reaching approximately $22,344, representing a 76% month-over-month increase from April's $12,670. The company also received a purchase order on June 2, 2026, with a retail product value of approximately $58,823 and a wholesale price of about $29,411.
The acquisition of VerdaGenix LLC d/b/a Ancient Extracts USA closed in mid-May, meaning the reported May revenue reflects only a partial month under UNLOCKD ownership. Management emphasized that these figures are preliminary, unaudited, and subject to adjustment. Despite the early stage of integration, the company sees the results as validation of the acquisition's potential.
CEO John P. Gorst stated, "We remain in the early stages of integrating Ancient Extracts into the UNLOCKD organization, but we are encouraged by the commercial momentum we are seeing. The combination of accelerating revenue, customer demand, and expanding distribution opportunities reinforces our belief that Ancient Extracts possesses many of the qualities that originally attracted us to this acquisition."
Ancient Extracts USA offers a portfolio of functional mushroom products, ceremonial teas, cacao blends, matcha, shilajit, and wellness goods under the brand philosophy "Ancient Remedies for Modern Life." The company believes the brand is well-positioned to benefit from growing consumer interest in functional mushrooms, adaptogens, and botanical wellness products.
Chairman and Chief Science Officer Dr. Jordan P. Balencic commented, "When we evaluated Ancient Extracts, we believed the business possessed a number of attractive characteristics, including a differentiated product portfolio, a loyal customer base, a capital-efficient operating model, and multiple pathways for future growth. While it remains early in the integration process, the initial operating results and commercial traction we are seeing continue to reinforce our conviction in the opportunity."
Management views Ancient Extracts as a capital-efficient operating foundation for pursuing additional commercialization opportunities, strategic partnerships, product innovation, and expansion. Separately, the company's UNLOCKD Technologies division has initiated preliminary planning for future consumer health technology opportunities, including early-stage evaluation of point-of-care testing concepts and discussions with developers and potential partners. These initiatives are in conceptual stages and will follow a disciplined, milestone-driven approach with dedicated financing.
Dr. Balencic added, "Our objective is straightforward: grow revenue, expand distribution, strengthen our portfolio of wellness assets, and execute with discipline. We believe Ancient Extracts provides a strong operating nucleus capable of supporting broader growth initiatives across wellness, functional nutrition, cognitive health, and human optimization."
The company cautioned that no assurances can be provided regarding timing, financing, or success of future technology initiatives. For more information, visit www.unlockdinc.com or follow @BFCHco on X for verified updates.
